Human Phenotype Ontology 
Grandparent Node:
expand
Macrocytic anemia (HP:0001972)help
Parent Node:
expand
Megaloblastic anemia (HP:0001889)help
..Starting node
..expand
Pyrimidine-responsive megaloblastic anemia (HP:0003339)help
Term ID: 3339
Name: Pyrimidine-responsive megaloblastic anemia
Synonym: Anaemia corrected by uridylic acid and cytidylic acid; Anemia corrected by uridylic acid and cytidylic acid; Pyrimidine-responsive megaloblastic anaemia
Definition: A type of megaloblastic anemia that improves upon administration of pyrimidine supplements such as uridylic acid and cytidylic acid.
Comments:
Reference: HP:0003339
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandFolate-responsive megaloblastic anemia (HP:0004851) help
..expandFolate-unresponsive megaloblastic anemia (HP:0004826) help
..expandThiamine-responsive megaloblastic anemia (HP:0004860) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003339HP:0003339Pyrimidine-responsive megaloblastic anemia0UMPS CL E G H737212563OMIM:258900Orotic aciduria.135


Genes (1) :UMPS

Diseases (1) :OMIM:258900
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.